期刊文献+

术前序贯放化疗治疗局部巨块型宫颈癌的近期疗效 被引量:6

Short-term effect of preoperative sequential chemo-radiotherapy in the treatment of local bulky cervical cancer
下载PDF
导出
摘要 目的 研究术前序贯放化疗治疗局部巨块型宫颈癌的近期临床疗效.方法 67例Ⅰb2~Ⅱa期局部巨块型(癌灶直径>4 cm)宫颈癌患者随机分成研究组(35例)和对照组(32例).两组患者术前均给予盆腔外照射放疗,研究组分别于放疗前、后给予TP(紫杉醇+顺铂)方案化疗一程,对照组放疗期间给予顺铂周化疗.比较两组放化疗后近期有效率、手术病理完全缓解率、毒副反应等.结果 研究组放化疗后近期有效率94.28%,对照组96.87%,两组比较差异无统计学意义(P>0.05).两组均有较明显的骨髓抑制和消化道反应,但患者经治疗后均可耐受.手术病理完全缓解率:研究组14.29%,对照组15.62%,两组比较差异无统计学意义(P>0.05).结论 巨块型宫颈癌术前序贯放化疗和同步放化疗两者疗效相当.术前序贯放化疗操作更灵活,便于推广,使更多患者受益. Objective To study the short-term effect of preoperative sequential chemoradiotherapy in the treatment of local bulky cervical cancer.Methods 67 cases of local bulky cervical cancer at stage Ⅰ b2-Ⅱ a (foci of cancer > 4 cm) were randomly divided into study group (35 cases) and control group (32 cases).All patients received radiotherapy before operation.Study group was given TP model chemotherapy (paclitaxel + cisplatin) before and after radiotherapy,while control group was given eisplatin during radiotherapy.The short-term efficacy,pathologically complete regressiou (PCR) and toxicity of two groups were compared.Results The short-term efficacy of study group was 94.28%,and that of control group was 96.87%,without statistically significant difference betweeu two groups (P > 0.05).There were obvious myelosuppressiou and reaction of digestive tract in two groups,which patients could suffered after treatment.Pathologically complete regression of study group was 14.29%,and that of control group was 15.62%,without statistically significant difference between two groups (P > 0.05).Conclusions Preoperative sequential chemo-radiotherapy has equivalent efficacy to concurrent chemo-radiotherapy in the treatment of bulky cervical cancer.Preoperative sequential chemo-radiotherapy is more flexible in the treatment and will benefit more patients,worthy of promotion.
作者 廖妮虹
出处 《国际医药卫生导报》 2014年第9期1261-1263,共3页 International Medicine and Health Guidance News
关键词 宫颈癌 术前 序贯放化疗 同步放化疗 疗效 副作用 Cervical cancer Preoperative Sequential chemo-radiotherapy Concurrent chemo-radiotherapy Curative effect Side effect
  • 相关文献

参考文献7

二级参考文献36

  • 1吴琨,章文华,张蓉,李华,白萍,李晓光.219例子宫颈癌根治术的并发症分析[J].中华肿瘤杂志,2006,28(4):316-319. 被引量:63
  • 2程敏,吴令英.宫颈癌手术前后的综合治疗[J].国外医学(妇产科学分册),2006,33(4):243-246. 被引量:11
  • 3臧荣余.妇科盆腔手术保留盆腔神经丛的方式[J].中国癌症杂志,2006,16(11):907-910. 被引量:22
  • 4贺国丽,王世阆.子宫颈癌的综合治疗[J].海南医学,2007,18(8):122-124. 被引量:3
  • 5Yamakawa Y, Fujimura M, Hidaka T, et al. Neoadjuvant intraarterial infusion chemotherapy in patients witI1 stage I B2- III B2 cervicl cancer [J]. Gynecol onco1,2000,77 (2) :264.
  • 6WHO. World Health Organization report:comprehensive cervical canc- er control : a guide to essential practice [ R ]. World Health Organiza- tion Web Site ,2006.
  • 7Bae JH, Lee SJ , Lee A, et al. Neoadjuvant lisplatin and etoposide fol- lowed by radical hysterectomy for stage 1B-2B cervical cancer [J]. Avnewl Onco1.2008.111 ( 3 ) :444.
  • 8Katsumata N, Yasuda M, Takahashi F, et al. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial [ J ].Lancet, 2009,374:1331-1338.
  • 9Markman M, Blessing J, Rubin SC, et al. Phase Ⅱ trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study [ J ] Gynecol Oncol, 2006,101:436-440.
  • 10Pignata S, Breda E, Scambia G, et al. A phase Ⅱ study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study [ J ] . Crit Rev Oncol Hematol, 2008,66:229-236.

共引文献69

同被引文献47

引证文献6

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部